Jefferies Group LLC Fibrogen Inc Put Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $196,474 - $514,152	-19,300 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$18.57 - $35.68 $358,401 - $688,624	19,300 New	19,300 $513,000
Q2 2021 Aug 20, 2021	SELL	$18.57 - $35.68 $35.5 Million - $68.2 Million	-1,910,700 Reduced 99.0%	19,300 $514,000
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $35.3 Million - $67.8 Million	1,900,800 Added 6509.59%	1,930,000 $514,000
Q4 2019 Feb 13, 2020	BUY	$34.58 - $48.06 $1.01 Million - $1.4 Million	29,200 New	29,200 $1.25 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.